Yahoo
Morningstar

Morningstar

•

Oct 30, 2026

ResMed Inc.: ResMed Earnings: Volume Drives Solid Start, but Some Earnings Benefits Will Reverse

Symbols

RMD

Sector(s)

Healthcare

Rating

Current Price

232.56

Fair Value

Economic Moat

Stewardship

Summary

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Upgrade
Mobilize your Website
View Site in Mobile | Classic
Share by: